October 2, 2026 C-Path Partners with University of Arizona on Translational Research of Parkinson’s Disease in Women TUCSON, Ariz., October 6, 2026 — Critical Path Institute® (C-Path) today announced a research collaboration with the University
October 1, 2026 Federal Investment Launches National Facility Dedicated to Advancing Non-Animal Drug Development Tools BALTIMORE; TUCSON, Ariz.; and WASHINGTON, Oct. 1, 2026 — The National Center to Accelerate Cures (NCAC)...
October 1, 2026 GATC Health Joins C-Path’s New Approach Methodologies Developer Coalition TUCSON, Ariz., October 1, 2026 — Critical Path Institute's® (C-Path) New Approach Methodologies Developer Coalition...
September 24, 2026 Critical Path Institute Appoints Measurement Science Expert Elizabeth (Nicki) Bush as Vice President of the Clinical Outcome Assessment Program TUCSON, Ariz., September 24, 2026 — Critical Path Institute® (C-Path) today announced the appointment of Elizabeth (Nicki) Bush
September 17, 2026 CGIC 2026 is in the Books: The Path Forward Wednesday at #CGIC2026 closed out the conference with a focus on data sharing, patient voices, and emerging technologies.
September 16, 2026 C-Path’s #CGIC2026 Day 1 in the Books + What’s ahead on Wednesday Day 1 at #CGIC2026 set the tone for the conference.
September 15, 2026 C-Path’s Translational Therapeutics Accelerator Awards $1.7 Million Across Five BRIDGe Grants in Brain Health, Pediatrics and Rare Disease Five research teams advance small molecule, protein-based and gene therapy candidates for conditions where existing options fall s
August 27, 2026 From One to Millions: Julia Vitarello on a New Vision for Individualized Medicine "I'm very, very determined to play a role together with everyone at C-Path and others to try to make sure that the millions of...
August 25, 2026 Critical Path for Parkinson’s Announces Milestone Publication Highlighting FDA Support for Novel Biomarker to Advance Precision Medicine Strategies TUCSON, Ariz., August 25, 2026 — Critical Path Institute® (C-Path) today announced the publication of "Regulatory...
August 20, 2026 C-Path CEO Klaus Romero Talks One to Millions on The BioCentury Show Critical Path Institute’s One to Millions Initiative is using individualized rare disease therapies...